Skip to main content

Table 1 (abstract P715). Stage 1 Efficacy Results Overall and by AXL Status

From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018): Late-Breaking Abstracts

Back to article page